{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T00:09:33Z","timestamp":1794787773749,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LGF19H030006"],"award-info":[{"award-number":["LGF19H030006"]}]},{"name":"Ningbo Science and Technology Project","award":["2019C50100"],"award-info":[{"award-number":["2019C50100"]}]},{"name":"Huili Fund of Lihuili Hospital","award":["2022YB016"],"award-info":[{"award-number":["2022YB016"]}]},{"name":"Medical and Health Science and Technology Plan Project of Zhejiang Province","award":["2024KY1477"],"award-info":[{"award-number":["2024KY1477"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15191-6","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T15:39:40Z","timestamp":1755531580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA"],"prefix":"10.1038","volume":"15","author":[{"given":"Hua","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangshun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"15191_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. Non-alcoholic fatty liver disease - A global public health perspective. J. Hepatol. 70, 531\u2013544 (2019).","journal-title":"J. Hepatol."},{"key":"15191_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17925\/EE.2024.20.2.2","volume":"20","author":"D Leith","year":"2024","unstructured":"Leith, D., Lin, Y. Y. & Brennan, P. Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A deadly synergy. TouchREV Endocrinol. 20, 5\u20139 (2024).","journal-title":"TouchREV Endocrinol."},{"key":"15191_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/apt.15163","volume":"49","author":"S Sookoian","year":"2019","unstructured":"Sookoian, S. & Pirola, C. J. Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside. Aliment. Pharmacol. Ther. 49, 516\u2013527 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"15191_CR4","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.3390\/nu12103166","volume":"12","author":"A Mandala","year":"2020","unstructured":"Mandala, A., Janssen, R. C., Palle, S., Short, K. R. & Friedman, J. E. Pediatric non-alcoholic fatty liver disease: nutritional origins and potential molecular mechanisms. Nutrients 12, 3166 (2020).","journal-title":"Nutrients"},{"key":"15191_CR5","doi-asserted-by":"publisher","first-page":"20230670","DOI":"10.1515\/med-2023-0670","volume":"18","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study. Open. Med. (Wars). 18, 20230670 (2023).","journal-title":"Open. Med. (Wars)"},{"key":"15191_CR6","doi-asserted-by":"publisher","first-page":"175628482311742","DOI":"10.1177\/17562848231174299","volume":"16","author":"J Cai","year":"2023","unstructured":"Cai, J., Dong, J., Chen, D. & Ye, H. The effect of synbiotics in patients with NAFLD: a systematic review and meta-analysis. Th. Adv. Gastroenterol. 16, 17562848231174299 (2023).","journal-title":"Th. Adv. Gastroenterol."},{"key":"15191_CR7","doi-asserted-by":"publisher","first-page":"1190458","DOI":"10.3389\/fphar.2023.1190458","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design. Front. Pharmacol. 14, 1190458 (2023).","journal-title":"Front. Pharmacol."},{"key":"15191_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2468-1253(17)30146-2","volume":"2","author":"S Bellentani","year":"2017","unstructured":"Bellentani, S. & Tiribelli, C. Is it time to change NAFLD and NASH nomenclature? Lancet Gastroenterol. Hepatol. 2, 547\u2013548 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"15191_CR9","doi-asserted-by":"publisher","first-page":"e0230307","DOI":"10.1371\/journal.pone.0230307","volume":"15","author":"T Diedrich","year":"2020","unstructured":"Diedrich, T. et al. Characterization of the immune cell landscape of patients with NAFLD. PLoS One. 15, e0230307 (2020).","journal-title":"PLoS One"},{"key":"15191_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jhep.2020.06.004","volume":"73","author":"A Saviano","year":"2020","unstructured":"Saviano, A., Henderson, N. C. & Baumert, T. F. Single-cell genomics and spatial transcriptomics: discovery of novel cell States and cellular interactions in liver physiology and disease biology. J. Hepatol. 73, 1219\u20131230 (2020).","journal-title":"J. Hepatol."},{"key":"15191_CR11","doi-asserted-by":"crossref","unstructured":"Dallio, M. et al. Immunity as cornerstone of non-alcoholic fatty liver disease: the contribution of oxidative stress in the disease progression. Int. J. Mol. Sci. 22. (2021).","DOI":"10.3390\/ijms22010436"},{"key":"15191_CR12","doi-asserted-by":"publisher","first-page":"1150118","DOI":"10.3389\/fendo.2023.1150118","volume":"14","author":"SJ Park","year":"2023","unstructured":"Park, S. J., Garcia Diaz, J., Um, E. & Hahn, Y. S. Major roles of Kupffer cells and macrophages in NAFLD development. Front. Endocrinol. (Lausanne). 14, 1150118 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"15191_CR13","doi-asserted-by":"crossref","unstructured":"Peiseler, M. & Tacke, F. Inflammatory mechanisms underlying nonalcoholic steatohepatitis and the transition to hepatocellular carcinoma. Cancers. 13 (2021).","DOI":"10.3390\/cancers13040730"},{"key":"15191_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9339-2","volume":"17","author":"M Nati","year":"2016","unstructured":"Nati, M. et al. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev. Endocr. Metab. Disord. 17, 29\u201339 (2016).","journal-title":"Rev. Endocr. Metab. Disord"},{"issue":"Suppl 2","key":"15191_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12072-013-9468-6","volume":"7","author":"M Ganz","year":"2013","unstructured":"Ganz, M. & Szabo, G. Immune and inflammatory pathways in NASH. Hepatol. Int. 7(Suppl 2), 771\u2013781 (2013).","journal-title":"Hepatol. Int."},{"key":"15191_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.tem.2022.07.001","volume":"33","author":"JA Hoogerland","year":"2022","unstructured":"Hoogerland, J. A., Staels, B. & Dombrowicz, D. Immune-metabolic interactions in homeostasis and the progression to NASH. Trends Endocrinol. Metab. 33, 690\u2013709 (2022).","journal-title":"Trends Endocrinol. Metab."},{"key":"15191_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.26749","volume":"59","author":"S Sutti","year":"2014","unstructured":"Sutti, S. et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 59, 886\u2013897 (2014).","journal-title":"Hepatology"},{"key":"15191_CR18","doi-asserted-by":"publisher","first-page":"18045","DOI":"10.1038\/s41598-021-96966-5","volume":"11","author":"L Pantano","year":"2021","unstructured":"Pantano, L. et al. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Sci. Rep. 11, 18045 (2021).","journal-title":"Sci. Rep."},{"key":"15191_CR19","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3748\/wjg.v25.i15.1783","volume":"25","author":"S Sookoian","year":"2019","unstructured":"Sookoian, S. & Pirola, C. J. Repurposing drugs to target nonalcoholic steatohepatitis. World J. Gastroenterol. 25, 1783\u20131796 (2019).","journal-title":"World J. Gastroenterol."},{"key":"15191_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/hep.31149","volume":"71","author":"X Xiong","year":"2020","unstructured":"Xiong, X., Kuang, H., Liu, T. & Lin, J. D. A single-cell perspective of the mammalian liver in health and disease. Hepatology 71, 1467\u20131473 (2020).","journal-title":"Hepatology"},{"key":"15191_CR21","doi-asserted-by":"crossref","unstructured":"Dam, T. V., Toft, N. I. & Grontved, L. Cell-Type resolved insights into the Cis-Regulatory genome of NAFLD. Cells. 11 (2022).","DOI":"10.3390\/cells11050870"},{"key":"15191_CR22","doi-asserted-by":"publisher","first-page":"1301099","DOI":"10.3389\/fmolb.2024.1301099","volume":"11","author":"DH Wang","year":"2024","unstructured":"Wang, D. H. et al. Single-cell sequencing and multiple machine learning algorithms to identify key T-cell differentiation gene for progression of NAFLD cirrhosis to hepatocellular carcinoma. Front. Mol. Biosci. 11, 1301099 (2024).","journal-title":"Front. Mol. Biosci."},{"key":"15191_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41575-020-0304-x","volume":"17","author":"P Ramachandran","year":"2020","unstructured":"Ramachandran, P., Matchett, K. P., Dobie, R., Wilson-Kanamori, J. R. & Henderson, N. C. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat. Rev. Gastroenterol. Hepatol. 17, 457\u2013472 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"15191_CR24","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1038\/s41598-021-98806-y","volume":"11","author":"ZY Wang","year":"2021","unstructured":"Wang, Z. Y. et al. Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. Sci. Rep. 11, 19396 (2021).","journal-title":"Sci. Rep."},{"key":"15191_CR25","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","volume":"29","author":"R Dobie","year":"2019","unstructured":"Dobie, R. et al. Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis. Cell. Rep. 29, 1832\u201347e8 (2019).","journal-title":"Cell. Rep."},{"key":"15191_CR26","doi-asserted-by":"publisher","first-page":"13484","DOI":"10.1038\/s41598-022-16754-7","volume":"12","author":"RG Fred","year":"2022","unstructured":"Fred, R. G. et al. Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis. Sci. Rep. 12, 13484 (2022).","journal-title":"Sci. Rep."},{"key":"15191_CR27","doi-asserted-by":"publisher","first-page":"103233","DOI":"10.1016\/j.isci.2021.103233","volume":"24","author":"Q Su","year":"2021","unstructured":"Su, Q. et al. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience 24, 103233 (2021).","journal-title":"iScience"},{"key":"15191_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"15191_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"15191_CR30","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","volume":"184","author":"BA Luca","year":"2021","unstructured":"Luca, B. A. et al. Atlas of clinically distinct cell States and ecosystems across human solid tumors. Cell 184, 5482\u201396e28 (2021).","journal-title":"Cell"},{"key":"15191_CR31","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen, C. B. et al. The landscape of tumor cell States and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 39, 1422\u201337e10 (2021).","journal-title":"Cancer Cell."},{"key":"15191_CR32","doi-asserted-by":"publisher","first-page":"16140","DOI":"10.1038\/s41598-024-67213-4","volume":"14","author":"G Zhang","year":"2024","unstructured":"Zhang, G. et al. Immune cell landscapes are associated with high-grade serous ovarian cancer survival. Sci. Rep. 14, 16140 (2024).","journal-title":"Sci. Rep."},{"key":"15191_CR33","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi, K. et al. Transcriptomics identify Thrombospondin-2 as a biomarker for NASH and advanced liver fibrosis. Hepatology 74, 2452\u20132466 (2021).","journal-title":"Hepatology"},{"key":"15191_CR34","doi-asserted-by":"publisher","first-page":"eaba4448","DOI":"10.1126\/scitranslmed.aba4448","volume":"12","author":"O Govaere","year":"2020","unstructured":"Govaere, O. et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci. Transl Med. 12, eaba4448 (2020).","journal-title":"Sci. Transl Med."},{"key":"15191_CR35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","volume":"51","author":"S Heeboll","year":"2016","unstructured":"Heeboll, S. et al. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. Scand. J. Gastroenterol. 51, 456\u2013464 (2016).","journal-title":"Scand. J. Gastroenterol."},{"key":"15191_CR36","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"15191_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"key":"15191_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/bioinformatics\/btm563","volume":"24","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P., Zhang, B. & Horvath, S. Defining clusters from a hierarchical cluster tree: the dynamic tree cut package for R. Bioinformatics 24, 719\u2013720 (2008).","journal-title":"Bioinformatics"},{"key":"15191_CR39","first-page":"1791","volume":"33","author":"W Liu","year":"2017","unstructured":"Liu, W., Li, L., Ye, H. & Tu, W. [Weighted gene co-expression network analysis in biomedicine research. Sheng Wu Gong. Cheng Xue Bao. 33, 1791\u20131801 (2017).","journal-title":"Sheng Wu Gong. Cheng Xue Bao"},{"key":"15191_CR40","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2796.2011.02427.x","volume":"270","author":"F Ponten","year":"2011","unstructured":"Ponten, F., Schwenk, J. M., Asplund, A. & Edqvist, P. H. The human protein atlas as a proteomic resource for biomarker discovery. J. Intern. Med. 270, 428\u2013446 (2011).","journal-title":"J. Intern. Med."},{"key":"15191_CR41","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"15191_CR42","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41591-023-02602-2","volume":"29","author":"TJ Kendall","year":"2023","unstructured":"Kendall, T. J. et al. An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nat. Med. 29, 2939\u20132953 (2023).","journal-title":"Nat. Med."},{"key":"15191_CR43","doi-asserted-by":"crossref","unstructured":"Ma, W. et al. Unveiling the pathogenesis of non-alcoholic fatty liver disease by decoding biomarkers through integrated single-cell and single-nucleus profiles. medRxiv. 2023.10.05.23296635 (2023).","DOI":"10.1101\/2023.10.05.23296635"},{"key":"15191_CR44","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb). 2, 100141 (2021).","journal-title":"Innov. (Camb)"},{"key":"15191_CR45","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"15191_CR46","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier, A., Zoete, V. & Michielin, O. SwissDock, a protein-small molecule Docking web service based on EADock DSS. Nucleic Acids Res. 39, W270\u2013W277 (2011).","journal-title":"Nucleic Acids Res."},{"key":"15191_CR47","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"15191_CR48","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081 (2017).","journal-title":"PLoS Genet."},{"key":"15191_CR49","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A., Timpson, N. & Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163 (2008).","journal-title":"Stat. Med."},{"key":"15191_CR50","doi-asserted-by":"publisher","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","volume":"17","author":"Z Lin","year":"2021","unstructured":"Lin, Z., Deng, Y. & Pan, W. Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet. 17, e1009922 (2021).","journal-title":"PLoS Genet."},{"key":"15191_CR51","doi-asserted-by":"crossref","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 7 (2018).","DOI":"10.7554\/eLife.34408"},{"key":"15191_CR52","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","volume":"45","author":"B Gyorffy","year":"2023","unstructured":"Gyorffy, B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience 45, 1889\u20131898 (2023).","journal-title":"Geroscience"},{"key":"15191_CR53","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.cmet.2024.08.010","volume":"36","author":"X Wei","year":"2024","unstructured":"Wei, X. et al. Myeloid beta-arrestin 2 depletion attenuates metabolic dysfunction-associated steatohepatitis via the metabolic reprogramming of macrophages. Cell. Metab. 36, 2281\u20132297 (2024). e7.","journal-title":"Cell. Metab."},{"key":"15191_CR54","doi-asserted-by":"publisher","first-page":"e10947","DOI":"10.15252\/msb.202210947","volume":"18","author":"L Niu","year":"2022","unstructured":"Niu, L. et al. Dynamic human liver proteome atlas reveals functional insights into disease pathways. Mol. Syst. Biol. 18, e10947 (2022).","journal-title":"Mol. Syst. Biol."},{"key":"15191_CR55","doi-asserted-by":"publisher","first-page":"658547","DOI":"10.3389\/fonc.2021.658547","volume":"11","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. ITGA3 is associated with immune cell infiltration and serves as a favorable prognostic biomarker for breast cancer. Front. Oncol. 11, 658547 (2021).","journal-title":"Front. Oncol."},{"key":"15191_CR56","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/hep.30318","volume":"69","author":"NO Davidson","year":"2019","unstructured":"Davidson, N. O. Tie-ing up angiogenesis to treat nonalcoholic steatohepatitis. Hepatology 69, 937\u2013939 (2019).","journal-title":"Hepatology"},{"key":"15191_CR57","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe, R. F., Tabas, I. & Pajvani, U. B. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158, 1913\u20131928 (2020).","journal-title":"Gastroenterology"},{"key":"15191_CR58","first-page":"4529","volume":"19","author":"X Shi","year":"2019","unstructured":"Shi, X. et al. Research progress on the PI3K\/AKT signaling pathway in gynecological cancer (Review). Mol. Med. Rep. 19, 4529\u20134535 (2019).","journal-title":"Mol. Med. Rep."},{"key":"15191_CR59","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 10, 7252\u20137259 (2004).","journal-title":"Clin. Cancer Res."},{"key":"15191_CR60","doi-asserted-by":"publisher","first-page":"e17116","DOI":"10.1016\/j.heliyon.2023.e17116","volume":"9","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Exploring the potential of treating chronic liver disease targeting the PI3K\/Akt pathway and polarization mechanism of macrophages. Heliyon 9, e17116 (2023).","journal-title":"Heliyon"},{"key":"15191_CR61","doi-asserted-by":"publisher","first-page":"472432","DOI":"10.1155\/2013\/472432","volume":"2013","author":"S Matsuda","year":"2013","unstructured":"Matsuda, S., Kobayashi, M. & Kitagishi, Y. Roles for PI3K\/AKT\/PTEN pathway in cell signaling of nonalcoholic fatty liver disease. ISRN Endocrinol. 2013, 472432 (2013).","journal-title":"ISRN Endocrinol."},{"key":"15191_CR62","doi-asserted-by":"publisher","first-page":"115242","DOI":"10.1016\/j.bcp.2022.115242","volume":"205","author":"C Ma","year":"2022","unstructured":"Ma, C., Han, L., Zhu, Z., Heng Pang, C. & Pan, G. Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochem. Pharmacol. 205, 115242 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"15191_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","volume":"19","author":"M Balakrishnan","year":"2021","unstructured":"Balakrishnan, M. et al. Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: A systematic review and Meta-analysis. Clin. Gastroenterol. Hepatol. 19, 61\u201371 (2021). e15.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"15191_CR64","doi-asserted-by":"publisher","first-page":"1070605","DOI":"10.3389\/fgene.2023.1070605","volume":"14","author":"H Ye","year":"2023","unstructured":"Ye, H. et al. Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease. Front. Genet. 14, 1070605 (2023).","journal-title":"Front. Genet."},{"key":"15191_CR65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby, T. & Gautier, E. L. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat. Rev. Immunol. 22, 429\u2013443 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"15191_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nut.2016.09.001","volume":"34","author":"T Charytoniuk","year":"2017","unstructured":"Charytoniuk, T., Drygalski, K., Konstantynowicz-Nowicka, K., Berk, K. & Chabowski, A. Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials. Nutrition 34, 108\u2013117 (2017).","journal-title":"Nutrition"},{"key":"15191_CR67","doi-asserted-by":"publisher","first-page":"H240","DOI":"10.1111\/1750-3841.13157","volume":"81","author":"DQ Zhang","year":"2016","unstructured":"Zhang, D. Q. et al. Resveratrol regulates activated hepatic stellate cells by modulating NF-kappaB and the PI3K\/Akt signaling pathway. J. Food Sci. 81, H240\u2013H245 (2016).","journal-title":"J. Food Sci."},{"key":"15191_CR68","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/mnfr.200800331","volume":"53","author":"R Lappano","year":"2009","unstructured":"Lappano, R. et al. Structure-activity relationships of resveratrol and derivatives in breast cancer cells. Mol. Nutr. Food Res. 53, 845\u2013858 (2009).","journal-title":"Mol. Nutr. Food Res."},{"key":"15191_CR69","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00044-007-9055-2","volume":"17","author":"T Tripathi","year":"2008","unstructured":"Tripathi, T. & Saxena, A. K. 2D- QSAR studies on new stilbene derivatives of resveratrol as a new selective aryl hydrocarbon receptor. Med. Chem. Res. 17, 212\u2013218 (2008).","journal-title":"Med. Chem. Res."},{"key":"15191_CR70","doi-asserted-by":"crossref","unstructured":"Baldarelli, R. M., Smith, C. L., Ringwald, M., Richardson, J. E. & Bult, C. J. Mouse genome informatics G. Mouse genome informatics: an integrated knowledgebase system for the laboratory mouse. Genetics ;227 (2024).","DOI":"10.1093\/genetics\/iyae031"},{"key":"15191_CR71","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1091\/mbc.e06-03-0217","volume":"18","author":"A Majdalawieh","year":"2007","unstructured":"Majdalawieh, A., Zhang, L. & Ro, H. S. Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation. Mol. Biol. Cell. 18, 930\u2013942 (2007).","journal-title":"Mol. Biol. Cell."},{"key":"15191_CR72","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2353\/ajpath.2009.080856","volume":"174","author":"SL Schissel","year":"2009","unstructured":"Schissel, S. L. et al. Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis. Am. J. Pathol. 174, 818\u2013828 (2009).","journal-title":"Am. J. Pathol."},{"key":"15191_CR73","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI92863","volume":"128","author":"T Teratani","year":"2018","unstructured":"Teratani, T. et al. Aortic carboxypeptidase-like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis. J. Clin. Invest. 128, 1581\u20131596 (2018).","journal-title":"J. Clin. Invest."},{"key":"15191_CR74","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.3748\/wjg.v27.i43.7563","volume":"27","author":"MA De Roza","year":"2021","unstructured":"De Roza, M. A. et al. Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study. World J. Gastroenterol. 27, 7563\u20137571 (2021).","journal-title":"World J. Gastroenterol."},{"key":"15191_CR75","doi-asserted-by":"publisher","first-page":"730534","DOI":"10.3389\/fnins.2021.730534","volume":"15","author":"B Huang","year":"2021","unstructured":"Huang, B. & Li, X. The role of Mfsd2a in nervous system diseases. Front. Neurosci. 15, 730534 (2021).","journal-title":"Front. Neurosci."},{"key":"15191_CR76","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.intimp.2016.02.033","volume":"34","author":"L Tao","year":"2016","unstructured":"Tao, L., Ding, Q., Gao, C. & Sun, X. Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. Int. Immunopharmacol. 34, 165\u2013172 (2016).","journal-title":"Int. Immunopharmacol."},{"key":"15191_CR77","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1016\/j.prmcm.2023.100233","volume":"6","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya, S., Perris, A., Jawed, J. J. & Hoda, M. Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action. Pharmacol. Res. Mod. Chin. Med. 6, 100233 (2023).","journal-title":"Pharmacol. Res. Mod. Chin. Med."},{"key":"15191_CR78","doi-asserted-by":"crossref","unstructured":"Ma, W. et al. A novel gene-screening approach reveals QSOX1\/IL1RAP as promising biomarkers for the severity of non-alcoholic fatty liver disease. MedRxiv 2023:2023.07.26.23293038.","DOI":"10.1101\/2023.07.26.23293038"},{"key":"15191_CR79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cei\/uxae077","volume":"218","author":"B Verstappe","year":"2024","unstructured":"Verstappe, B. & Scott, C. L. Implementing distinct spatial proteogenomic technologies: opportunities, challenges, and key considerations. Clin. Exp. Immunol. 218, 151\u2013162 (2024).","journal-title":"Clin. Exp. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15191-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:28:32Z","timestamp":1757402912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15191-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15191-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30233"}}